World's Best Scientists 2026 revealed!
Amy P. Abernethy

Amy P. Abernethy

D-Index & Metrics

Medicine

D-Index
103
Citations
40707
World Ranking
7338
National Ranking
3841

Overview

Amy P. Abernethy is affiliated with Duke University in the United States and specializes in Medicine with a focus on a range of subfields and research topics. Their work encompasses significant contributions across Economics and Econometrics, Public Health, Environmental and Occupational Health, General Health Professions, Oncology, and Pediatrics, Perinatology and Child Health.

Their main topics of research include Health Systems, Economic Evaluations, and Quality of Life; Palliative Care and End-of-Life Issues; Economic and Financial Impacts of Cancer; Childhood Cancer Survivors' Quality of Life; Ethics in Clinical Research; Cancer Survivorship and Care; and Healthcare Cost, Quality, and Practices.

Abernethy's frequent coauthors demonstrate a collaborative profile and include Joseph B. Franklin, Bryce B. Reeve, Ethan Basch, Arif H. Kamal, and Jane L. Wheeler.

Publications by Amy P. Abernethy show contributions to notable journals and venues. Frequent publication venues for their work include UNC Libraries, NAM Perspectives, JAMA, Clinical Pharmacology & Therapeutics, and The Lancet Digital Health.

Key recent papers authored or coauthored by the scientist include:

  • The Promise of Digital Health: Then, Now, and the Future, 2022, NAM Perspectives
  • Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs, 2022, NAM Perspectives
  • The Integration of Clinical Trials With the Practice of Medicine, 2024, JAMA
  • Diversity, Equity, and Inclusion in Clinical Research: A Path Toward Precision Health for Everyone, 2022, Clinical Pharmacology & Therapeutics
  • Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness: A Randomized Clinical Trial, 2020, UNC Libraries

Best Publications

  • American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care

    Thomas J. Smith;Sarah Temin;Erin R. Alesi;Amy P. Abernethy

  • Generalist plus Specialist Palliative Care — Creating a More Sustainable Model

    Timothy E. Quill;Amy P. Abernethy

  • Mobile health technology evaluation: The mHealth evidence workshop

    Santosh Kumar;Wendy J. Nilsen;Amy Abernethy;Audie Atienza

  • The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

    S. Yousuf Zafar;Jeffrey M. Peppercorn;Deborah Schrag;Donald H. Taylor

  • Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Ethan Basch;Ethan Basch;Bryce B. Reeve;Sandra A. Mitchell;Steven B. Clauser

  • Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Amylou C. Dueck;Tito R. Mendoza;Sandra A. Mitchell;Bryce B. Reeve

  • Families looking back: one year after discussion of withdrawal or withholding of life-sustaining support.

    BA Katherine H. Abbott;Joni G. Sago;Catherine M. Breen;Amy P. Abernethy

  • Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea

    Amy P Abernethy;David C Currow;Peter Frith;Belinda S Fazekas

  • Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

    Jennifer S Temel;Amy P Abernethy;David C Currow;John Friend

  • Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial

    Amy P Abernethy;Amy P Abernethy;Amy P Abernethy;Christine F McDonald;Peter A Frith;Katherine Clark

  • The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]

    Amy P Abernethy;Amy P Abernethy;Amy P Abernethy;Tania Shelby-James;Belinda S Fazekas;David Woods

  • Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness a randomized clinical trial

    Jean S. Kutner;Patrick J. Blatchford;Donald H. Taylor;Christine S. Ritchie;Christine S. Ritchie

  • Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology

    Ethan Basch;Amy P. Abernethy;C. Daniel Mullins;Bryce B. Reeve

  • Oncologist Communication About Emotion During Visits With Patients With Advanced Cancer

    Kathryn I. Pollak;Robert M. Arnold;Amy S. Jeffreys;Stewart C. Alexander

  • Financial toxicity, Part I: a new name for a growing problem.

    Zafar Sy;Abernethy Ap

  • Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database

    Gaurav Singal;Gaurav Singal;Peter G. Miller;Vineeta Agarwala;Gerald Li

  • Conflict associated with decisions to limit life-sustaining treatment in intensive care units

    Catherine M. Breen;Amy P. Abernethy;Katherine H. Abbott;James A. Tulsky

  • Patient experiences with communication about sex during and after treatment for cancer.

    Kathryn E. Flynn;Jennifer Barsky Reese;Diana D. Jeffery;Amy P. Abernethy

  • Unmet spiritual care needs impact emotional and spiritual well-being in advanced cancer patients

    Michelle J. Pearce;April D. Coan;James E. Herndon;Harold G. Koenig;Harold G. Koenig

  • PSYCHOLOGICAL APPROACHES TO UNDERSTANDING AND TREATING DISEASE-RELATED PAIN

    Francis J. Keefe;Amy P. Abernethy;Lisa C. Campbell

Frequent Co-Authors

David C. Currow
David C. Currow Flinders University
Gregory P. Samsa
Gregory P. Samsa Duke University
James A. Tulsky
James A. Tulsky Harvard University
James E. Herndon
James E. Herndon Duke University
Deborah Schrag
Deborah Schrag Harvard University
David Cella
David Cella Northwestern University
Ethan Basch
Ethan Basch University of North Carolina at Chapel Hill
Bryce B. Reeve
Bryce B. Reeve Duke University
Jennifer S. Temel
Jennifer S. Temel Harvard University
Francis J. Keefe
Francis J. Keefe Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to various health-related fields and online learning options. Many students choose alternative career paths that offer flexibility, affordability, and growing job prospects.

For those interested in pharmaceuticals, the 3 year online pharmd program enables you to become a Doctor of Pharmacy remotely and in an accelerated timeframe.

If technology and information management are your strengths, consider a health information technology online degree, which prepares graduates for roles handling medical data and health records in digital environments.

The administrative side of healthcare is also accessible, with options like a low cost medical coding and billing online program that trains students for in-demand support roles from home.

Nursing remains a popular choice, and the cheapest fnp programs help registered nurses expand their qualifications and become family nurse practitioners at a lower cost.

Exploring these related online degrees can provide flexible career pathways for those passionate about health but looking for options beyond traditional medical school routes.

Best Scientists Citing Amy P. Abernethy

Trending Scientists

Recently Published Articles